Please upgrade your browser.
Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center presented a poster on a phase I clinical trial of Nivolumab, a PD-1 receptor blocking antibody, being used in combination with other drugs in patients with metastatic renal cell carcinoma (mRCC) at the ASCO Annual Meeting.
Focus on colon, breast cancer drug
"Everything has shrunk," said the 62-year-old contractor from Wolcott, Connecticut, who still goes for treatment every two weeks and has regular scans to keep tabs on his progress. "Some of the tumors you can't even see."
Can statin drugs help prevent kidney cancer? This edition also includes a link to videos that will help you to learn how to take your anti-cancer drug, along with information about side effects.
Kidney Cancer Association and Conquer Cancer Foundation work together to promote and sponsor research projects.
A pre-filtered list of abstracts related to renal cell carcinoma (RCC) from the 2013 Annual Meeting of the American Society of Clinical Oncology, held this week in Chicago.
We have launched a patient registry for kidney cancer.
ASONEP is a humanized antibody that binds to and neutralizes sphingosine-1-phosphate (S1P). S1P is a bioactive lipid that has been validated as a drug target in multiple sclerosis and that has been shown to contribute to progression of several cancer types.
Founding registry partners voice strong support for the shared, open-access registry able to collect data on any disease, from rare to common.
Members of the Kidney Cancer Association Nurse Advisory Board discuss targeted therapies and management of side effects.
|NeonCRM by Neon One|